Smith & Nephew Plc

WHO'M
ai
Digital Profiler. Simply click the AI button
CUSIP

G82343164
SEDOL

0922320
CIK

N/A

smith-nephew.com
LEI: 213800ZTMDN8S67S1H61
FIGI: BBG000C6PDH8
SN

Smith & Nephew Plc
GICS: 35101010 · Sector: Health Care · Sub-Sector: Health Care
AI
PROFILER
NAME
Smith & Nephew Plc
ISIN
GB0009223206
TICKER
SN
MIC
XLON
REUTERS
SN..L
BLOOMBERG
SN. LN
FOR INVESTORS
FOR TRADERS
Securities Trading Warrants

GlobeNewswire is an important news source that provides investors with company-related information. In particular, it deals with events that may be relevant to the listing of companies or tradable financial instruments. You can access the complete overview of all reports via this link.

Mon, 03.02.2025

Healthcare professionals are invited to register for the livestream option as a courtesy here

Tue, 14.01.2025

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces that ECRI – leaders in advancing evidence-based healthcare globally - have completed updated Clinical Evidence Assessments of ALLEVYN LIFE Sacrum Foam Dressings and the LEAF Patient Monitoring System. In their latest reports, ECRI upgraded its Evidence Bar ratings for both to favorable* after assessing the most recently published clinical evidence and key outcomes for pressure injury prevention.

Thu, 19.12.2024

Latest expansion to the CORI Surgical System portfolio provides a personalized solution for patients and surgeons

Mon, 16.12.2024

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces it has received 510(k) clearance from the United States Food & Drug Administration for a stemless anatomic total shoulder for the AETOS Shoulder System (AETOS Stemless). 

Wed, 16.10.2024

Smith+Nephew (LSE: SN, NYSE: SNN), the global medical technology company, is proud to announce that its RENASYS EDGE Negative Pressure Wound Therapy (NPWT) System has won the Red Dot Award for Design Concept 2024 in the Medical Devices and Technology Category, recognizing its intuitive pairing of NPWT housed in a patient-friendly design.

Wed, 09.10.2024

Patented technology further personalizes total knee arthroplasty for surgeons and patients

Wed, 18.09.2024

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces promising surgeon feedback from the first completed cases utilizing its new CATALYSTEM Primary Hip System. Designed to address the evolving demands of primary hip surgery - including the increased adoption of anterior approach procedures – the CATALYSTEM Primary Hip System features a triple-taper stem design with uniform proximal loading.1  The reduced distal stem geometry and shorter lengths are ideal for anterior approach but suitable for all approaches.2

Tue, 10.09.2024

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces the launch of its TOTAL ANKLE Patient-Matched Guides, giving surgeons a predictable and efficient option to help plan and perform total ankle replacement (TAR) procedures. Engineered using 3D Systems’ VSP® surgical planning workflows, all-in-one TOTAL ANKLE Patient-Matched Guides are designed to achieve a precise patient fit using fluoroscopic alignment cues and efficient instrumentation, and provide accuracy to plan.1-8

Wed, 26.06.2024

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces it will sponsor tennis players participating in The Championships, Wimbledon 2024 to spotlight its advanced Sports Medicine portfolio alongside some of the greatest athletes in the world. Smith+Nephew endeavours to help people live their ‘Life Unlimited’ by aiding in their recovery from injury and get them back to doing what they love.

We are different
OPEN FINANCIAL
DATA & KNOWLEDGE HUB
We make the difference
Information on product placements

 

SMART * AD
EN GIF 970X250

P R O D U C T   S U G G E S T I O N S